הדוחות הכספיים המלאים לרבעון השלישי של 2019
false
טבע תעשיות פרמצבטיות בע"מ
2
380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no:
520013954
11947
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
08/11/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-109378
Time of broadcast:
01:40
01:36:11
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
הדוחות הכספיים המלאים לרבעון השלישי של 2019
Q3_2019_Form_10-Q_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NYSE
Date of revision of form structure:
29/10/2019
Address:
P.O.B
3190
,
Petach Tikva
49131
,
Tel:
03-9267267
,
03-9267652
Fax:
03-9267519
E-mail address:
tomer.amitai@teva.co.il
Previous names of reporting entity:
Name of the Signatory:
MCCLELLAN MICHAEL
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Address:
Basel
5
,
Petach-Tikva
4951033
Telephone:
03-9148213
Facsimile:
03-9148671
E-mail:
Michael.McClellan@tevapharm.com
1